Cigna Corporation Peer Comparison
| Metric | Value | Ranking | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $95.2 Billion | 2/7 | UNH $546.9B |
CI $95.2B |
CVS $78.3B |
CNC $38.2B |
HUM $29.7B |
MOH $19.4B |
ALHC $2.2B |
| Gross Margin | 84% | 5/7 | UNH 100% |
MOH 100% |
ALHC 100% |
HUM 89% |
CI 84% |
CNC 21% |
CVS 15% |
| Profit Margin | 3% | 2/7 | UNH 4% |
CI 3% |
CNC 3% |
MOH 3% |
CVS 2% |
HUM 2% |
ALHC -4% |
| EBITDA margin | 4% | 3/7 | CVS 5% |
MOH 5% |
CI 4% |
HUM 4% |
CNC 3% |
UNH 1% |
ALHC -2% |
| Quarterly Revenue | $60.5 Billion | 3/7 | UNH $97.9B |
CVS $91.3B |
CI $60.5B |
CNC $39.8B |
HUM $29.5B |
MOH $9.9B |
ALHC $681.3M |
| Quarterly Earnings | $1.5 Billion | 3/7 | UNH $4.2B |
CVS $1.8B |
CI $1.5B |
CNC $1.1B |
HUM $679.0M |
MOH $301.0M |
ALHC -$24.0M |
| Quarterly Free Cash Flow | -$105.0 Billion | 5/7 | UNH $5.9B |
CVS $2.5B |
CNC $2.0B |
ALHC $11.8M |
CI -$105.0M |
MOH -$246.0M |
HUM -$0 |
| Trailing 4 Quarters Revenue | $217.9 Billion | 3/7 | UNH $384.4B |
CVS $363.3B |
CI $217.9B |
CNC $157.7B |
HUM $112.0B |
MOH $37.4B |
ALHC $2.2B |
| Trailing 4 Quarters Earnings | $2.7 Billion | 4/7 | UNH $97.9B |
CVS $91.3B |
CI $60.5B |
CNC $39.8B |
HUM $29.5B |
MOH $9.9B |
ALHC $681.3M |
| Quarterly Earnings Growth | 6% | 3/7 | ALHC 16% |
CNC 8% |
CI 6% |
MOH -3% |
CVS -7% |
UNH -23% |
HUM -29% |
| Annual Earnings Growth | -49% | 6/7 | ALHC -9% |
CVS -13% |
MOH -16% |
UNH -37% |
CNC -37% |
CI -49% |
HUM -63% |
| Quarterly Revenue Growth | 24% | 2/7 | ALHC 47% |
CI 24% |
MOH 18% |
HUM 10% |
UNH 7% |
CNC 6% |
CVS 3% |
| Annual Revenue Growth | 16% | 2/7 | ALHC 25% |
CI 16% |
MOH 14% |
CVS 5% |
UNH 5% |
HUM 5% |
CNC 2% |
| Cash On Hand | $6.8 Billion | 4/7 | UNH $31.3B |
CNC $17.6B |
CVS $12.6B |
CI $6.8B |
HUM $5.5B |
MOH $4.4B |
ALHC $341.1M |
| Short Term Debt | $1.7 Billion | 3/7 | UNH $11.4B |
CVS $5.6B |
CI $1.7B |
HUM $1.1B |
CNC $112.0M |
MOH -$0 |
ALHC -$0 |
| Long Term Debt | $30.1 Billion | 3/7 | UNH $63.7B |
CVS $62.6B |
CI $30.1B |
CNC $17.5B |
HUM $11.7B |
MOH $2.2B |
ALHC $211.7M |
| PE | 35.50 | 2/7 | UNH 38.78 |
CI 35.50 |
MOH 18.29 |
HUM 17.35 |
CNC 13.53 |
CVS 10.89 |
ALHC -1.00 |
| PS | 0.44 | 4/7 | UNH 1.42 |
ALHC 0.97 |
MOH 0.52 |
CI 0.44 |
HUM 0.26 |
CNC 0.24 |
CVS 0.22 |
| PB | 2.29 | 4/7 | ALHC 17.28 |
MOH 4.01 |
UNH 2.46 |
CI 2.29 |
HUM 1.77 |
CNC 1.39 |
CVS 1.04 |
| PC | 14.03 | 2/7 | UNH 17.46 |
CI 14.03 |
ALHC 6.32 |
CVS 6.23 |
HUM 5.39 |
MOH 4.47 |
CNC 2.17 |
| Liabilities to Equity | 2.65 | 2/7 | ALHC 4.78 |
CI 2.65 |
CVS 2.37 |
MOH 2.14 |
CNC 2.04 |
HUM 2.00 |
UNH 0.00 |
| ROA | 0.02 | 6/7 | MOH 7% | UNH 5% | CVS 3% | CNC 3% | HUM 3% | CI 2% | ALHC -21% |
| ROE | 0.06 | 5/7 | MOH 22% |
CVS 10% |
CNC 10% |
HUM 10% |
CI 6% |
UNH -100% |
ALHC -124% |
| Current Ratio | 1.38 | 6/7 | UNH 4.49 |
HUM 1.50 |
CNC 1.49 |
MOH 1.47 |
CVS 1.42 |
CI 1.38 |
ALHC 1.21 |
| Quick Ratio | 0.06 | 7/7 | UNH 38.78 |
CI 35.50 |
MOH 18.29 |
HUM 17.35 |
CNC 13.53 |
CVS 10.89 |
ALHC -1.00 |
| Long Term Debt to Equity | 0.73 | 3/7 | ALHC} 1.71 |
CVS} 0.84 |
CI} 0.73 |
HUM} 0.70 |
CNC} 0.64 |
MOH} 0.45 |
UNH} -1.00 |
| Debt to Equity | 0.77 | 3/7 | ALHC 1.78 |
CVS 1.12 |
CI 0.77 |
HUM 0.77 |
CNC 0.64 |
MOH 0.49 |
UNH -1.00 |
| Burn Rate | 78.77 | 1/7 | CI 78.77 |
HUM 70.44 |
UNH 26.64 |
ALHC 10.50 |
CVS 5.85 |
MOH -20.37 |
CNC -42.18 |
| Cash to Cap | 0.07 | 6/7 | CNC 0.46 |
MOH 0.22 |
HUM 0.19 |
CVS 0.16 |
ALHC 0.16 |
CI 0.07 |
UNH 0.06 |
| CCR | -0.07 | 4/7 | CNC 1.74 |
UNH 1.40 |
CVS 1.38 |
CI -0.07 |
ALHC -0.49 |
MOH -0.82 |
HUM |
| EV to EBITDA | 49.90 | 2/7 | UNH} 724.82 |
CI} 49.90 |
MOH} 36.40 |
CVS} 34.08 |
CNC} 31.10 |
HUM} 28.92 |
ALHC} -172.38 |
| EV to Revenue | 0.55 | 3/7 | UNH 1.54 |
ALHC 0.91 |
CI 0.55 |
MOH 0.47 |
CVS 0.41 |
HUM 0.33 |
CNC 0.24 |